VprBP executes its pro-melanomagenic function in a H2AT120p-dependent manner, as selective mutation and pharmacological inhibition eliminating VprBP kinase activity restore the expression of aberrantly silenced growth-regulatory genes in melanoma cells. The gene discussed is DCAF1; the disease is melanoma.